Bank of Montreal Can grew its holdings in shares of National HealthCare Co. (NYSE:NHC – Free Report) by 48.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,684 shares of the company’s stock after purchasing an additional 1,861 shares during the quarter. Bank of Montreal Can’s holdings in National HealthCare were worth $611,000 at the end of the most recent quarter.
Several other hedge funds have also made changes to their positions in the business. JPMorgan Chase & Co. grew its holdings in National HealthCare by 46.6% in the 4th quarter. JPMorgan Chase & Co. now owns 63,145 shares of the company’s stock valued at $6,792,000 after buying an additional 20,072 shares during the period. Barclays PLC increased its holdings in shares of National HealthCare by 345.6% during the 3rd quarter. Barclays PLC now owns 21,063 shares of the company’s stock worth $2,649,000 after buying an additional 16,336 shares during the last quarter. Prudential Financial Inc. raised its position in shares of National HealthCare by 98.2% in the 4th quarter. Prudential Financial Inc. now owns 28,192 shares of the company’s stock worth $3,032,000 after buying an additional 13,970 shares during the period. KLP Kapitalforvaltning AS acquired a new position in National HealthCare in the fourth quarter valued at $854,000. Finally, Ellsworth Advisors LLC purchased a new stake in National HealthCare during the fourth quarter valued at about $650,000. Institutional investors and hedge funds own 56.44% of the company’s stock.
National HealthCare Stock Up 0.6 %
Shares of NYSE NHC opened at $92.13 on Monday. National HealthCare Co. has a 12-month low of $87.62 and a 12-month high of $138.49. The stock has a fifty day moving average price of $93.77 and a 200 day moving average price of $107.35. The company has a current ratio of 1.80, a quick ratio of 1.77 and a debt-to-equity ratio of 0.14. The company has a market cap of $1.42 billion, a P/E ratio of 11.55 and a beta of 0.42.
National HealthCare Dividend Announcement
Analysts Set New Price Targets
Separately, StockNews.com lowered National HealthCare from a “strong-buy” rating to a “buy” rating in a research note on Monday, March 3rd.
Read Our Latest Analysis on National HealthCare
National HealthCare Company Profile
National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities.
Featured Stories
- Five stocks we like better than National HealthCare
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- With a 60%+ Upside, There’s Plenty to Love About Lovesac
- What Are Growth Stocks and Investing in Them
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- AppLovin: Can Record Profits Overcome Market Skepticism?
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.